Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

Home > Adults > Investigations >

Community Diagnostic Centres

Checked: 15-03-2024 by 5 Rob Adams Next Review: 15-03-2026


Thousands more diagnostic tests will be available for NHS patients in BNSSG, with the opening of two new Community Diagnostic Centres (CDCs) in April 2024.

CDCs will be delivered in partnership with:

  • InHealth (formerly PRIME Endoscopy)
  • University Hospitals Bristol and Weston NHS Foundation Trust (UHBW)
  • North Bristol NHS Trust (NBT)

Referral pathways for diagnostic tests will remain unchanged.


North Bristol CDC

The North Bristol CDC will be based at Cribbs Causeway, next to Asda. Services will initially be provided from mobile units at the site before moving into the permanent building later in 2024.

The following services will be provided by InHealth staff:

  • Endoscopy (excluding Urgent Suspected Cancer (USC) referrals) -  continue to request in the usual way using the appropriate BNSSG standard referral forms as outlined on the Endoscopy page. The BNSSG endoscopy forms are also available in EMIS. Older or obsolete forms should no longer be used. The Prime Millenium square endoscopy site will no longer be available.
  • CT scans
  • MRI scans
  • X-Ray - plain films
  • Ultrasound
  • Echocardiography - see ECHO - requesting page for referral criteria
  • Respiratory Physiology tests - see Spirometry and Lung Function Tests for referral criteria.


Weston CDC

The CDC in Weston will be based at the For All Healthy Living Centre on Lonsdale Avenue, BS23 3SJ.

The following investigations should be requested in the usual way. The services will be provided by InHealth staff:

UHBW staff will also be utilising space within the CDC to operate some additional services. For the 2024/2025 year this will be

  • Electrocardiogram (ECG)
  • Blood Pressure (BP) ambulatory monitoring
  • Sleep Studies - referral restrictions apply as detailed on the Obstructive Sleep Apnoea (OSA) page.

Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.